Literature DB >> 8235239

Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients.

M Suzuki1, K Otsuka, C Guilleminault.   

Abstract

We investigated the way in which nasal continuous positive airway pressure (CPAP) affects the circadian profiles of blood pressure (BP) and heart rate (HR) in obstructive sleep apnea syndrome (OSAS) patients. Nine patients with OSAS, confirmed by nocturnal polysomnography, were studied with ambulatory blood pressure monitoring (Colin ABPM-630) during two 48-hour periods, before and during nasal CPAP treatment, at the Stanford University Sleep Disorders Clinic. During each 48-hour monitoring period, blood pressure measurements were taken by the ambulatory device every 30 minutes. During the ambulatory blood pressure recordings, nocturnal sleep time was defined as the period between 0000 hours to 0600 hours and active daytime was defined as the period between 1000 hours and 2000 hours. An average systolic blood pressure > 135 mm Hg during the 48-hour baseline recording was defined as hypertensive. Using these criteria, we selected four hypertensive and five normotensive patients. Average BP (systolic/diastolic) and HR during the 48-hour periods decreased significantly from 148.6/88.2 mm Hg to 138.7/81.4 mm Hg, and from 77.9 beats per minute (bpm) to 67.2 bpm in hypertensives during CPAP treatment (p = 0.04), but there were no significant changes observed in normotensives. Average BP, during the day and at night, decreased from 152.3/91.8 mm Hg to 141.2/85.1 mm Hg and from 133.9/76.8 mm Hg to 125.9/73.7 mm Hg, respectively, in the hypertensives during CPAP, but such changes were not observed in normotensives. Average HR during the day and at night decreased significantly from 85.2 bpm to 72.6 bpm and from 69.8 bpm to 56.5 bpm in the hypertensives (p = 0.04), but not in normotensives.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8235239     DOI: 10.1093/sleep/16.6.545

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  20 in total

Review 1.  CPAP therapy: outcomes and patient use.

Authors:  N J Douglas; H M Engleman
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  Sympatho-adrenal activation by chronic intermittent hypoxia.

Authors:  Nanduri R Prabhakar; Ganesh K Kumar; Ying-Jie Peng
Journal:  J Appl Physiol (1985)       Date:  2012-06-21

Review 3.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

4.  The ineffectiveness of magnotherapy in a patient with obstructive sleep apnea syndrome and cardiovascular comorbidity.

Authors:  Yaron Dagan; Katy Borodkin
Journal:  Sleep Breath       Date:  2004-12       Impact factor: 2.816

Review 5.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

6.  The effect of oral appliance therapy on blood pressure in patients with obstructive sleep apnea.

Authors:  Ryo Otsuka; Fernanda Ribeiro de Almeida; Alan A Lowe; Wolfgang Linden; Frank Ryan
Journal:  Sleep Breath       Date:  2006-03       Impact factor: 2.816

Review 7.  Obstructive sleep apnea and severe mental illness: evolution and consequences.

Authors:  Wei-Chen Lin; John W Winkelman
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

8.  Sense and Sensitivity: Obstructive Sleep Apnea, Morning Blood Pressure, and Occult Hypertension.

Authors:  Richard J Castriotta
Journal:  J Clin Sleep Med       Date:  2017-07-15       Impact factor: 4.062

9.  Variables affecting the change in systemic blood pressure in response to nasal CPAP in obstructive sleep apnea patients.

Authors:  Junaid Malik; Christopher L Drake; David W Hudgel
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

10.  The role of compliance with PAP use on blood pressure in patients with obstructive sleep apnea: is longer use a key-factor?

Authors:  I Bouloukaki; C Mermigkis; N Tzanakis; K Giannadaki; E Mauroudi; V Moniaki; E M Kallergis; S E Schiza
Journal:  J Hum Hypertens       Date:  2016-07-28       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.